Lung Cancer Screening Guidelines Implementation in Primary Care: A Call to Action.
作者信息
Doubeni Chyke A, Wilkinson John M, Korsen Neil, Midthun David E
机构信息
Department of Family Medicine, Mayo Clinic College of Medicine and Science, Rochester, Minnesota
Center for Health Equity and Community Engagement Research, Mayo Clinic College of Medicine and Science, Rochester, Minnesota.
出版信息
Ann Fam Med. 2020 May;18(3):196-201. doi: 10.1370/afm.2541.
Abstract
摘要
相似文献
1
Lung Cancer Screening Guidelines Implementation in Primary Care: A Call to Action.基层医疗中肺癌筛查指南的实施：行动呼吁
Ann Fam Med. 2020 May;18(3):196-201. doi: 10.1370/afm.2541.
2
Lung cancer screening: national consensus is an important step toward implementation.肺癌筛查：全国共识是迈向实施的重要一步。
Adv Respir Med. 2018;86(1):1-2. doi: 10.5603/ARM.2018.0001.
3
Improving the Implementation of Lung Cancer Screening Guidelines at an Academic Primary Care Practice.在学术性初级保健机构中改进肺癌筛查指南的实施情况。
J Healthc Qual. 2018 Jan/Feb;40(1):27-35. doi: 10.1097/JHQ.0000000000000089.
4
Lung Cancer Screening: Pros and Cons.肺癌筛查：利弊
Am Fam Physician. 2019 Jun 15;99(12):740-742.
5
Expanded Lung and Colorectal Cancer Screening - Ensuring Equity and Safety under New Guidelines.扩大肺癌和结直肠癌筛查——在新指南下确保公平性和安全性
N Engl J Med. 2022 Jan 13;386(2):100-102. doi: 10.1056/NEJMp2113332. Epub 2022 Jan 8.
6
Evaluating efficacy of current lung cancer screening guidelines.评估现行肺癌筛查指南的有效性。
J Med Screen. 2017 Dec;24(4):208-213. doi: 10.1177/0969141316689111. Epub 2017 Feb 15.
7
Recommendations on screening for lung cancer.肺癌筛查建议。
CMAJ. 2016 Apr 5;188(6):425-432. doi: 10.1503/cmaj.151421. Epub 2016 Mar 7.
8
Evaluating Lung Cancer Screening Across Diverse Healthcare Systems: A Process Model from the Lung PROSPR Consortium.评估不同医疗体系中的肺癌筛查：来自 Lung PROSPR 联盟的过程模型。
Cancer Prev Res (Phila). 2020 Feb;13(2):129-136. doi: 10.1158/1940-6207.CAPR-19-0378. Epub 2019 Dec 23.
9
CT screening for lung cancer: Are we ready to implement in Europe?肺癌 CT 筛查：我们是否准备好在欧洲实施？
Lung Cancer. 2019 Aug;134:25-33. doi: 10.1016/j.lungcan.2019.05.028. Epub 2019 May 28.
10
Off the mark: Current lung cancer screening guidelines miss those most at risk.不准确：当前的肺癌筛查指南遗漏了风险最高的人群。
Cancer. 2015 Aug 1;121(15):2477-8. doi: 10.1002/cncr.28999.
引用本文的文献
1
Updates on lung cancer screening for early detection.肺癌早期检测筛查的最新进展。
Korean J Intern Med. 2025 Jul;40(4):546-556. doi: 10.3904/kjim.2025.008. Epub 2025 Jul 1.
2
Evaluating Pragmatism of Lung Cancer Screening Randomized Trials with the PRECIS-2 Tool.使用PRECIS-2工具评估肺癌筛查随机试验的实用性
J Am Board Fam Med. 2025 May 12;38(1):56-83. doi: 10.3122/jabfm.2024.240142R1.
3
Innovations in Early Lung Cancer Detection: Tracing the Evolution and Advancements in Screening.早期肺癌检测的创新：探寻筛查技术的演变与进展
J Clin Med. 2024 Aug 20;13(16):4911. doi: 10.3390/jcm13164911.
4
Identifying Populations at Risk for Lung Cancer Mortality from the National Health and Nutrition Examination Survey (2001-2018) Using the 2021 USPSTF Screening Guidelines.使用 2021 年 USPSTF 筛查指南从国家健康和营养检查调查（2001-2018 年）中确定肺癌死亡率风险人群。
Int J Environ Res Public Health. 2024 Jun 15;21(6):781. doi: 10.3390/ijerph21060781.
5
Predictors of Discussing Lung Cancer Screening with a Health Care Provider Among Current and Former Smokers in HINTS: A Secondary Data Analysis.在 HINTS 中，当前和曾经吸烟者与医疗保健提供者讨论肺癌筛查的预测因素：二次数据分析。
Cancer Control. 2022 Jan-Dec;29:10732748221130567. doi: 10.1177/10732748221130567.
6
European lung cancer screening: valuable trial evidence for optimal practice implementation.欧洲肺癌筛查：最佳实践实施的有价值的试验证据。
Br J Radiol. 2022 May 1;95(1133):20200260. doi: 10.1259/bjr.20200260. Epub 2022 Jan 7.
7
Consistency of recommendations for the diagnosis and treatment of non-small cell lung cancer: a systematic review.非小细胞肺癌诊断与治疗建议的一致性：一项系统综述
Transl Lung Cancer Res. 2021 Jun;10(6):2715-2732. doi: 10.21037/tlcr-21-423.
8
Understanding the patient journey to diagnosis of lung cancer.了解肺癌诊断过程中的患者旅程。
BMC Cancer. 2021 Apr 14;21(1):402. doi: 10.1186/s12885-021-08067-1.
9
Potential Disparities by Sex and Race or Ethnicity in Lung Cancer Screening Eligibility Rates.潜在的性别、种族或民族差异对肺癌筛查资格率的影响。
Chest. 2021 Jul;160(1):341-350. doi: 10.1016/j.chest.2021.01.070. Epub 2021 Feb 3.
10
Biopsy frequency and complications among lung cancer patients in the United States.美国肺癌患者的活检频率及并发症情况。
Lung Cancer Manag. 2020 Aug 17;9(4):LMT40. doi: 10.2217/lmt-2020-0022.
本文引用的文献
1
Results of Lung Cancer Screening in the Community.社区肺癌筛查结果。
Ann Fam Med. 2020 May;18(3):243-249. doi: 10.1370/afm.2519.
2
Lung Cancer Screening Registry Reveals Low-dose CT Screening Remains Heavily Underutilized.肺癌筛查登记处显示，低剂量 CT 筛查的使用率仍然很低。
Clin Lung Cancer. 2020 May;21(3):e206-e211. doi: 10.1016/j.cllc.2019.09.002. Epub 2019 Sep 26.
3
Reduced Lung-Cancer Mortality with Volume CT Screening in a Randomized Trial.随机试验中 CT 容积筛查降低肺癌死亡率
N Engl J Med. 2020 Feb 6;382(6):503-513. doi: 10.1056/NEJMoa1911793. Epub 2020 Jan 29.
4
Cancer statistics, 2020.癌症统计数据，2020 年。
CA Cancer J Clin. 2020 Jan;70(1):7-30. doi: 10.3322/caac.21590. Epub 2020 Jan 8.
5
Evaluating Lung Cancer Screening Across Diverse Healthcare Systems: A Process Model from the Lung PROSPR Consortium.评估不同医疗体系中的肺癌筛查：来自 Lung PROSPR 联盟的过程模型。
Cancer Prev Res (Phila). 2020 Feb;13(2):129-136. doi: 10.1158/1940-6207.CAPR-19-0378. Epub 2019 Dec 23.
6
Lung Cancer Incidence and Mortality with Extended Follow-up in the National Lung Screening Trial.国家肺癌筛查试验中延长随访后的肺癌发病率和死亡率。
J Thorac Oncol. 2019 Oct;14(10):1732-1742. doi: 10.1016/j.jtho.2019.05.044. Epub 2019 Jun 28.
7
Benefits and harms in the National Lung Screening Trial: expected outcomes with a modern management protocol.国家肺癌筛查试验中的获益与危害：采用现代管理方案的预期结果
Lancet Respir Med. 2019 Aug;7(8):655-656. doi: 10.1016/S2213-2600(19)30136-5. Epub 2019 May 7.
8
Prolonged lung cancer screening reduced 10-year mortality in the MILD trial: new confirmation of lung cancer screening efficacy.MILD 试验证实：延长肺癌筛查时间可降低 10 年死亡率，再次确认肺癌筛查的有效性。
Ann Oncol. 2019 Jul 1;30(7):1162-1169. doi: 10.1093/annonc/mdz117.
9
Estimation of Overdiagnosis of Lung Cancer in Low-Dose Computed Tomography Screening: A Secondary Analysis of the Danish Lung Cancer Screening Trial.低剂量计算机断层扫描筛查中肺癌过度诊断的估计：丹麦肺癌筛查试验的二次分析。
JAMA Intern Med. 2018 Oct 1;178(10):1420-1422. doi: 10.1001/jamainternmed.2018.3056.
10
Modifiable Failures in the Colorectal Cancer Screening Process and Their Association With Risk of Death.结直肠癌筛查过程中的可修正失败及其与死亡风险的关联。
Gastroenterology. 2019 Jan;156(1):63-74.e6. doi: 10.1053/j.gastro.2018.09.040. Epub 2018 Sep 27.
Zotero 插件